Cash · 2011–2025
Emergent Biosolutions cash
$205M+106.4% · FY2025
Emergent Biosolutions (EBS) reported $205M in cash for fiscal 2025, +106.4% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $205M | +106.4% | Open → |
| FY20242024-12-31 | $99.5M | −10.9% | Open → |
| FY20232023-12-31 | $112M | −82.6% | Open → |
| FY20222022-12-31 | $643M | +11.5% | Open → |
| FY20212021-12-31 | $576M | −7.3% | Open → |
| FY20202020-12-31 | $621M | +270.3% | Open → |
| FY20192019-12-31 | $168M | +49.6% | Open → |
| FY20182018-12-31 | $112M | −37.1% | Open → |
| FY20172017-12-31 | $178M | −34.3% | Open → |
| FY20162016-12-31 | $272M | −13.2% | Open → |
| FY20152015-12-31 | $313M | +11.5% | Open → |
| FY20142014-12-31 | $280M | +56.4% | Open → |
| FY20132013-12-31 | $179M | +26.6% | Open → |
| FY20122012-12-31 | $142M | −1.6% | Open → |
| FY20112011-12-31 | $144M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +2.6%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions cash |url=https://companiesranked.com/en/company/emergent-biosolutions/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions cash. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/cash-on-handBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001367644-26-000082 · August 6, 2026
{{cite web |title=Emergent Biosolutions cash — 10-Q (0001367644-26-000082) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000082/ebs-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.